133 related articles for article (PubMed ID: 15983230)
1. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
Laukkanen O; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetes; 2005 Jul; 54(7):2256-60. PubMed ID: 15983230
[TBL] [Abstract][Full Text] [Related]
2. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.
Kilpeläinen TO; Lakka TA; Laaksonen DE; Laukkanen O; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Physiol Genomics; 2007 Oct; 31(2):264-72. PubMed ID: 17636114
[TBL] [Abstract][Full Text] [Related]
3. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
[TBL] [Abstract][Full Text] [Related]
4. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
Kubaszek A; Pihlajamäki J; Komarovski V; Lindi V; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetes; 2003 Jul; 52(7):1872-6. PubMed ID: 12829659
[TBL] [Abstract][Full Text] [Related]
5. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study.
Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetologia; 2004 May; 47(5):871-7. PubMed ID: 15127203
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
[TBL] [Abstract][Full Text] [Related]
7. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.
Müssig K; Staiger H; Machicao F; Stancáková A; Kuusisto J; Laakso M; Thamer C; Machann J; Schick F; Claussen CD; Stefan N; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2009 Apr; 94(4):1353-60. PubMed ID: 19141580
[TBL] [Abstract][Full Text] [Related]
8. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
[TBL] [Abstract][Full Text] [Related]
9. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study.
Mager U; Lindi V; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Pulkkinen L; Uusitupa M;
Diabet Med; 2006 Jun; 23(6):685-9. PubMed ID: 16759313
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study.
Salopuro T; Pulkkinen L; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
Int J Obes (Lond); 2005 Oct; 29(10):1245-51. PubMed ID: 15997246
[TBL] [Abstract][Full Text] [Related]
11. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
Andrulionytè L; Zacharova J; Chiasson JL; Laakso M;
Diabetologia; 2004 Dec; 47(12):2176-84. PubMed ID: 15592662
[TBL] [Abstract][Full Text] [Related]
12. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
Kilpeläinen TO; Lakka TA; Laaksonen DE; Mager U; Salopuro T; Kubaszek A; Todorova B; Laukkanen O; Lindström J; Eriksson JG; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
Metabolism; 2008 Mar; 57(3):428-36. PubMed ID: 18249219
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.
Andrulionyte L; Laukkanen O; Chiasson JL; Laakso M;
J Mol Med (Berl); 2006 Aug; 84(8):701-8. PubMed ID: 16838170
[TBL] [Abstract][Full Text] [Related]
14. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.
Siitonen N; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M
Diabetologia; 2004 Aug; 47(8):1416-24. PubMed ID: 15309292
[TBL] [Abstract][Full Text] [Related]
15. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Zacharova J; Chiasson JL; Laakso M;
Diabetes; 2005 Mar; 54(3):893-9. PubMed ID: 15734870
[TBL] [Abstract][Full Text] [Related]
16. The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia.
Heni M; Ketterer C; Hart LM; Ranta F; van Haeften TW; Eekhoff EM; Dekker JM; Boomsma DI; Nijpels G; Kramer MH; Diamant M; Simonis-Bik AM; Heine RJ; de Geus EJ; Schäfer SA; Machicao F; Ullrich S; Thamer C; Stefan N; Staiger H; Häring HU; Fritsche A
J Clin Endocrinol Metab; 2010 Dec; 95(12):E479-84. PubMed ID: 20826583
[TBL] [Abstract][Full Text] [Related]
17. [Molecular biological approach to impaired glucose tolerance].
Mori H; Kasuga M
Nihon Rinsho; 1996 Oct; 54(10):2795-8. PubMed ID: 8914447
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Andrulionyte L; Kuulasmaa T; Chiasson JL; Laakso M;
Diabetes; 2007 Apr; 56(4):1181-6. PubMed ID: 17317762
[TBL] [Abstract][Full Text] [Related]
19. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
Lindi VI; Uusitupa MI; Lindström J; Louheranta A; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Tuomilehto J;
Diabetes; 2002 Aug; 51(8):2581-6. PubMed ID: 12145174
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats.
David-Silva A; Freitas HS; Okamoto MM; Sabino-Silva R; Schaan BD; Machado UF
Life Sci; 2013 Nov; 93(22):805-13. PubMed ID: 24157454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
